HealthStream (NASDAQ:HSTM) Posts Earnings Results, Beats Estimates By $0.02 EPS

HealthStream (NASDAQ:HSTM) announced its quarterly earnings data on Monday. The technology company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.02, Zacks reports. HealthStream had a return on equity of 5.82% and a net margin of 6.93%.

HealthStream Stock Performance

Shares of NASDAQ:HSTM traded up $0.89 during trading on Monday, reaching $21.24. 702,896 shares of the stock traded hands, compared to its average volume of 350,183. The stock has a market cap of $630.15 million, a P/E ratio of 31.24, a price-to-earnings-growth ratio of 2.20 and a beta of 0.44. The stock has a 50-day moving average of $22.01 and a two-hundred day moving average of $24.93. HealthStream has a 52-week low of $19.50 and a 52-week high of $34.13.

Insider Buying and Selling at HealthStream

In other news, Director Tate Deborah Taylor sold 1,580 shares of HealthStream stock in a transaction that occurred on Wednesday, November 26th. The shares were sold at an average price of $25.46, for a total value of $40,226.80. Following the completion of the sale, the director directly owned 23,127 shares in the company, valued at $588,813.42. The trade was a 6.39% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Kevin P. O’hara sold 2,000 shares of HealthStream stock in a transaction on Monday, December 8th. The stock was sold at an average price of $24.26, for a total value of $48,520.00. Following the completion of the sale, the executive vice president directly owned 16,373 shares of the company’s stock, valued at $397,208.98. The trade was a 10.89% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 5,680 shares of company stock worth $139,336. Insiders own 20.50% of the company’s stock.

Institutional Investors Weigh In On HealthStream

Institutional investors have recently added to or reduced their stakes in the stock. Invesco Ltd. boosted its position in shares of HealthStream by 0.9% during the fourth quarter. Invesco Ltd. now owns 151,691 shares of the technology company’s stock worth $3,500,000 after acquiring an additional 1,307 shares during the last quarter. Susquehanna Portfolio Strategies LLC purchased a new position in shares of HealthStream during the fourth quarter valued at about $721,000. Numerai GP LLC grew its position in shares of HealthStream by 13.8% during the fourth quarter. Numerai GP LLC now owns 77,026 shares of the technology company’s stock valued at $1,777,000 after purchasing an additional 9,339 shares in the last quarter. Millennium Management LLC increased its holdings in shares of HealthStream by 188.2% in the fourth quarter. Millennium Management LLC now owns 64,507 shares of the technology company’s stock worth $1,488,000 after purchasing an additional 42,124 shares during the last quarter. Finally, Man Group plc lifted its position in shares of HealthStream by 177.0% in the fourth quarter. Man Group plc now owns 50,718 shares of the technology company’s stock worth $1,170,000 after buying an additional 32,406 shares in the last quarter. 69.58% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on HSTM. Weiss Ratings downgraded shares of HealthStream from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday. Wall Street Zen lowered HealthStream from a “buy” rating to a “hold” rating in a research note on Saturday, November 22nd. Canaccord Genuity Group set a $25.00 price target on shares of HealthStream in a report on Thursday, January 8th. Finally, Citigroup restated a “market perform” rating on shares of HealthStream in a report on Tuesday, January 6th. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, HealthStream presently has a consensus rating of “Hold” and an average target price of $25.00.

HealthStream declared that its Board of Directors has initiated a stock repurchase program on Tuesday, November 11th that permits the company to repurchase $10.00 million in outstanding shares. This repurchase authorization permits the technology company to reacquire up to 1.3% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s board believes its stock is undervalued.

HealthStream Company Profile

HealthStream, Inc is a Nashville, Tennessee–based provider of workforce development and learning management solutions for healthcare organizations. Since its founding in 1990, the company has focused on helping hospitals, clinics and other care providers streamline staff training, ensure regulatory compliance and monitor employee performance. HealthStream’s platform integrates online courses, skill competency assessments and credential management tools to support workforce readiness across the healthcare continuum.

The company’s core offerings include a learning management system (LMS) designed specifically for clinical and nonclinical personnel, a competency management suite that tracks skill acquisition and validation, and a content library featuring evidence-based clinical and compliance training modules.